Cost vs Efficacy
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
COG ARST1431 Protocol A (VAC/VI Only) N/A - secondary systemic drug | — | R 235 695 | 28d | — | — | — | — | — |
COG ARST1431 Protocol B (VAC/VI and Temsirolimus) N/A - secondary systemic drug Partial | — | R 235 695 | 28d | — | — | — | — | — |
COG ARST0531 VAC/VI Arm N/A - secondary systemic drug | — | R 31 853 | — | — | — | — | — | — |
COG ARST0531 VAC Arm N/A - secondary systemic drug | — | R 27 395 | — | — | — | — | — | — |
4 of 4 regimens shown